SLNSW-AtezoTRIBE: a randomised phase II study of FOLFOX...-TN_cdi_doaj_primary_oai_doaj_org_article_9d9f7151e67a49a2a5095a5c6c078498

AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer

Full title: AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer

Author/creator: Antoniotti, Carlotta, Borelli, Beatrice, Rossini, Daniele, Pietrantonio, Filippo, Morano, Federica, Salvatore, Lisa, Lonardi, Sara, Marmorino, Federica, Tamberi, Stefano, Corallo, Salvatore, Tortora, Giampaolo, Bergamo, Francesca, Brunella, Di Stefano, Boccaccino, Alessandra, Grassi, Elisa, Racca, Patrizia, Tamburini, Emiliano, Aprile, Giuseppe, Moretto, Roberto, Boni, Luca, Falcone, Alfredo, Cremolini, Chiara.

Call Numbers:

Record Identifier: TN_cdi_doaj_primary_oai_doaj_org_article_9d9f7151e67a49a2a5095a5c6c078498

Language: English

Formats: Articles

Publishers: England: BioMed Central Ltd

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9d9f7151e67a49a2a5095a5c6c078498

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer

    Record identifier

    TN_cdi_doaj_primary_oai_doaj_org_article_9d9f7151e67a49a2a5095a5c6c078498

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9d9f7151e67a49a2a5095a5c6c078498

    Share

    AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9d9f7151e67a49a2a5095a5c6c078498

    AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer

    Full title

    AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer

    Author / Creator

    Antoniotti, Carlotta ; Borelli, Beatrice ; Rossini, Daniele ; Pietrantonio, Filippo ; Morano, Federica ; Salvatore, Lisa ; Lonardi, Sara ; Marmorino, Federica ; Tamberi, Stefano ; Corallo, Salvatore ; Tortora, Giampaolo ; Bergamo, Francesca ; Brunella, Di Stefano ; Boccaccino, Alessandra ; Grassi, Elisa ; Racca, Patrizia ; Tamburini, Emiliano ; Aprile, Giuseppe ; Moretto, Roberto ; Boni, Luca ; Falcone, Alfredo ; Cremolini, Chiara

    Publisher

    England: BioMed Central Ltd

    Journal title

    BMC cancer, 2020, Vol.20 (1), p.683-9

    Record Identifier

    TN_cdi_doaj_primary_oai_doaj_org_article_9d9f7151e67a49a2a5095a5c6c078498

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    Aged Analysis Antibodies, Monoclonal, Humanized - administration & dosage Antigens Antineoplastic Agents - administration & dosage Antineoplastic Agents, Immunological - administration & dosage Antineoplastic Combined Chemotherapy Protocols - administration & dosage Apoptosis Atezolizumab Bevacizumab Bevacizumab - administration & dosage Camptothecin - administration & dosage Camptothecin - analogs & derivatives Cancer Cancer patients Cancer therapies Care and treatment CD8 antigen Cell death Chemotherapy Clinical trials Colorectal cancer Colorectal carcinoma Colorectal Neoplasms - drug therapy Colorectal Neoplasms - genetics Colorectal Neoplasms - pathology Cytotoxic agents Cytotoxicity Drug Administration Schedule Endothelial growth factors Fluorouracil - administration & dosage FOLFOXIRI Humans Immune checkpoint inhibitors Immune response Immunogenicity Immunomodulation Immunotherapy Italy Leucovorin - administration & dosage Lymphocytes Lymphocytes T Metastases Metastasis Metastatic colorectal cancer Microsatellite Instability Microsatellite status Mismatch repair Monoclonal antibodies Neoantigens Organoplatinum Compounds - administration & dosage Patients Prospective Studies Safety Solid tumors Study Protocol Suppressor cells T cells Targeted cancer therapy Triplet Tumors Vascular endothelial growth factor

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_doaj_primary_oai_doaj_org_article_9d9f7151e67a49a2a5095a5c6c078498

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9d9f7151e67a49a2a5095a5c6c078498

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections